Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck dB Cash Flow — Operating Cash Flow ($M) ($M)
Postgres DB financial_values (via lib/db.py)
Latest, Q2 2026
5,370
Period ended Jun 30, 2026
Change on a year earlier
+63.1%
3,293 in Q2 2025
History
68 quarters
Since Q3 2008
Sources
53
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | DB Cash Flow — Operating Cash Flow ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 5,370 | +63.1% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 3,918 | +56.7% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 2,857 | -17.2% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 7,822 | -15.8% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 3,293 | -41.6% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 2,500 | -19.1% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 3,450 | +1,302.4% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | 9,291 | +20.4% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 5,637 | +52.2% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,090 | +130.8% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 246 | -94.4% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 7,717 | +37.8% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 3,704 | -13.9% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 1,339 | -71.9% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | 4,430 | -13.1% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 5,602 | +16.8% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 4,302 | +116.2% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 4,761 | +284.0% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | 5,095 | +49.4% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 4,797 | +203.2% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,990 | +3.8% | Form 10-Q (filed 2022-05-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,240 | +75.4% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 3,410 | +1,332.8% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 1,582 | -62.6% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 1,918 | -37.8% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2020 | Mar 31, 2020 | 707 | -47.1% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 238 | -93.4% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | 4,226 | +51.3% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 3,084 | -8.8% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,336 | +15.7% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 3,592 | -10.6% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 2,793 | -338.5% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 3,382 | +2.0% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 1,155 | +303.8% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | 4,019 | +10.7% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | -1,171 | -139.4% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | 3,317 | +107.3% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | 286 | -86.8% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 3,632 | -14.5% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | 2,971 | -10.3% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | 1,600 | -40.7% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | 2,173 | -4.9% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 4,246 | -510.2% | SEC Filing ↗ |
| Q3 2015 | Sep 30, 2015 | 3,311 | -23.9% | SEC Filing ↗ |
| Q2 2015 | Jun 30, 2015 | 2,697 | +16.5% | SEC Filing ↗ |
| Q1 2015 | Mar 31, 2015 | 2,284 | -3.3% | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2014 | Dec 31, 2014 | -1,035 | – | SEC Filing ↗ |
| Q3 2014 | Sep 30, 2014 | 4,348 | -30.8% | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | 2,315 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | 2,361 | +0.9% | Form 10-Q (filed 2014-05-08) ↗ |
| Q2 2013 | Sep 30, 2013 | 6,287 | +100.3% | Form 10-Q (filed 2013-11-07) ↗ |
| Q1 2013 | Mar 31, 2013 | 2,341 | +8.7% | Form 10-Q (filed 2013-05-09) ↗ |
| Q4 2012 | Dec 31, 2012 | 1,809 | -44.0% | Form 10-K (filed 2013-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 3,139 | -31.4% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | 2,920 | – | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 2,154 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 3,233 | -8.6% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | 4,577 | +76.6% | Form 10-Q (filed 2011-11-08) ↗ |
| Q4 2010 | Dec 31, 2010 | 3,539 | +57.8% | Form 10-Q (filed 2011-11-08) ↗ |
| Q3 2010 | Sep 30, 2010 | 2,592 | -930.5% | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 3,325 | +343.9% | Form 10-Q (filed 2011-05-09) ↗ |
| Q1 2010 | Mar 31, 2010 | 1,366 | +91.7% | Form 10-Q (filed 2011-05-09) ↗ |
| Q4 2009 | Dec 31, 2009 | 2,243 | -43.9% | Form 10-Q (filed 2010-11-08) ↗ |
| Q3 2009 | Sep 30, 2009 | -312 | -126.2% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2009 | Jun 30, 2009 | 749 | – | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2009 | Mar 31, 2009 | 713 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2008 | Dec 31, 2008 | 3,997 | – | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2008 | Sep 30, 2008 | 1,191 | – | Form 10-Q (filed 2009-10-29) ↗ |
Breakdown
What makes up db cash flow — operating cash flow ($m)
- Capital Expenditures ($M)893 · Q2 2026
- Depreciation and Amortization ($M)599 · Q2 2026
- Stock-Based Compensation ($M)298 · Q2 2026
- Deferred Income Taxes ($M)-544 · Q2 2026
- Change in Accounts Receivable ($M)–
- Change in Inventories ($M)–
- Change in Trade Accounts Payable ($M)–
- Acquisitions of Businesses, Net of Cash Acquired ($M)0 · Q2 2026
- Purchases of Securities and Other Investments ($M)-148 · Q2 2026
- Net Cash Used in Investing Activities ($M)-5,602 · Q2 2026
- Proceeds from Issuance of Debt ($M)–
- Payments on Debt ($M)-5 · Q2 2026
- Dividends Paid to Stockholders ($M)-2,144 · Q2 2026
- Purchases of Treasury Stock ($M)-757 · Q2 2026
- Net Cash Used in Financing Activities ($M)1,762 · Q2 2026
- Effect of Exchange Rate Changes on Cash ($M)-37 · Q2 2026
- Net Increase (Decrease) in Cash and Cash Equivalents ($M)1,493 · Q2 2026
- Cash Paid for Interest ($M)654 · Q2 2026
- Cash Paid for Income Taxes ($M)–
Cite this data
StockData. (2026). Merck DB Cash Flow — Operating Cash Flow ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_cf_ocf
See every metric in the Merck KPI table. Data updated Oct 26, 2026.